Table of Contents
ISRN Transplantation
Volume 2013 (2013), Article ID 303175, 10 pages
http://dx.doi.org/10.5402/2013/303175
Review Article

Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis

1Division of Nephrology, Department of Internal Medicine, State University of New York at Buffalo, Buffalo, NY 14215, USA
2The Regional Center of Excellence for Transplantation and Kidney Care, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, USA

Received 11 February 2013; Accepted 20 March 2013

Academic Editors: A. Rydzewski, P. Toniutto, and A. Van Eyk

Copyright © 2013 Rabi Yacoub et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Cowper, Nephrogenic Fibrosing Dermopathy, ICNSFR, 2001–2009, http://www.icnsfr.org/.
  2. R. Kafi, G. J. Fisher, T. Quan et al., “UV-A1 phototherapy improves nephrogenic fibrosing dermopathy,” Archives of Dermatology, vol. 140, no. 11, pp. 1322–1324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. A. Jiménez, C. M. Artlett, N. Sandorfi et al., “Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor β1 expression in affected skin,” Arthritis and Rheumatism, vol. 50, no. 8, pp. 2660–2666, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. F. A. Mendoza, C. M. Artlett, N. Sandorfi, K. Latinis, S. Piera-Velazquez, and S. A. Jimenez, “Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature,” Seminars in Arthritis and Rheumatism, vol. 35, no. 4, pp. 238–249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Evenepoel, M. Zeegers, S. Segaert et al., “Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure,” Nephrology Dialysis Transplantation, vol. 19, no. 2, pp. 469–473, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. L. Moschella, J. Kay, B. T. Mackool, and V. Liu, “Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-2004. A 68-year-old man with end-stage renal disease and thickening of the skin,” The New England Journal of Medicine, vol. 351, no. 21, pp. 2219–2227, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Cowper, H. S. Robin, S. M. Steinberg, L. D. Su, S. Gupta, and P. E. LeBoit, “Scleromyxoedema-like cutaneous diseases in renal-dialysis patients,” The Lancet, vol. 356, no. 9234, pp. 1000–1001, 2000. View at Google Scholar · View at Scopus
  8. V. Hubbard, A. Davenport, M. Jarmulowicz, and M. Rustin, “Scleromyxoedema-like changes in four renal dialysis patients,” British Journal of Dermatology, vol. 148, no. 3, pp. 563–568, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Grobner, “Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?” Nephrology Dialysis Transplantation, vol. 21, no. 4, pp. 1104–1108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. R. Prince, H. Zhang, M. Morris et al., “Incidence of nephrogenic systemic fibrosis at two large medical centers,” Radiology, vol. 248, no. 3, pp. 807–816, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Altun, D. R. Martin, R. Wertman, A. Lugo-Somolinos, E. R. Fuller III, and R. C. Semelka, “Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy—report from two U.S. universities,” Radiology, vol. 253, no. 3, pp. 689–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Marckmann, L. Skov, K. Rossen et al., “Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging,” Journal of the American Society of Nephrology, vol. 17, no. 9, pp. 2359–2362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. E. A. Sadowski, L. K. Bennett, M. R. Chan et al., “Nephrogenic systemic fibrosis: risk factors and incidence estimation,” Radiology, vol. 243, no. 1, pp. 148–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. A. Collidge, P. C. Thomson, P. B. Mark et al., “Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort,” Radiology, vol. 245, no. 1, pp. 168–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Deo, M. Fogel, and S. E. Cowper, “Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 2, pp. 264–267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. D. J. Todd, A. Kagan, L. B. Chibnik, and J. Kay, “Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure,” Arthritis and Rheumatism, vol. 56, no. 10, pp. 3433–3441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. J. Chung and K. Y. Chung, “Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin,” British Journal of Dermatology, vol. 150, no. 3, pp. 596–597, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. P. W. Baron, K. Cantos, D. J. Hillebrand et al., “Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis,” American Journal of Dermatopathology, vol. 25, no. 3, pp. 204–209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Läuchli, C. Zortea-Caflisch, F. O. Nestle, G. Burg, and W. Kempf, “Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis,” Dermatology, vol. 208, no. 3, pp. 278–280, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Kintossou, M. D'Incan, D. Chauveau et al., “Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis: role of gadolinium?” Annales de Dermatologie et de Venereologie, vol. 134, no. 8-9, pp. 667–671, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Kay and W. A. High, “Imatinib mesylate treatment of nephrogenic systemic fibrosis,” Arthritis and Rheumatism, vol. 58, no. 8, pp. 2543–2548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Kadiyala, D. A. Roer, and M. A. Perazella, “Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate,” American Journal of Kidney Diseases, vol. 53, no. 1, pp. 133–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. D. Swartz, L. J. Crofford, S. H. Phan, R. W. Ike, and L. D. Su, “Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure,” American Journal of Medicine, vol. 114, no. 7, pp. 563–572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. L. R. Essary and M. R. Wick, “Cutaneous calciphylaxis: an underrecognized clinicopathologic entity,” American Journal of Clinical Pathology, vol. 113, no. 2, pp. 280–287, 2000. View at Google Scholar · View at Scopus
  25. M. Panesar, S. Banerjee, and G. W. Barone, “Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation,” Clinical Transplantation, vol. 22, no. 6, pp. 803–808, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Schieren, N. Wirtz, P. Altmeyer, L. C. Rump, S. M. Weiner, and A. Kreuter, “Nephrogenic systemic fibrosis-a rapidly progressive disabling disease with limited therapeutic options,” Journal of the American Academy of Dermatology, vol. 61, no. 5, pp. 868–874, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Wiedemeyer, H. Kutzner, J. L. Abraham et al., “The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report,” American Journal of Dermatopathology, vol. 31, no. 7, pp. 674–681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Leung, A. Shaikh, F. G. Cosio et al., “The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation,” American Journal of Transplantation, vol. 10, no. 3, pp. 558–562, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Mackay-Wiggan, D. J. Cohen, M. A. Hardy, E. H. Knobler, and M. E. Grossman, “Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease),” Journal of the American Academy of Dermatology, vol. 48, no. 1, pp. 55–60, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Hancox, Y. M. Mengesha, O. P. Sangueza, and G. Yosipovitch, “Nephrogenic fibrosing dermopathy after five days of hemodialysis,” Journal of Drugs in Dermatology, vol. 2, no. 5, pp. 550–553, 2003. View at Google Scholar
  31. M. A. Perazella, S. Ishibe, M. A. Perazella, and R. F. Reilly, “Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease,” Seminars in Dialysis, vol. 16, no. 3, pp. 276–280, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Jan, J. M. Segal, J. Dyer, P. LeBoit, E. Siegfried, and I. J. Frieden, “Nephrogenic fibrosing dermopathy: two pediatric cases,” Journal of Pediatrics, vol. 143, no. 5, pp. 678–681, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Levine, R. A. Taylor, L. B. Elman et al., “Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy),” Muscle and Nerve, vol. 30, no. 5, pp. 569–577, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Hauser, G. Kaya, and C. Chizzolini, “Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis,” Dermatology, vol. 209, no. 1, pp. 50–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. A. W. H. Tan, S. H. Tan, T. Y. Lian, and S. K. Ng, “A case of nephrogenic fibrosing dermopathy,” Annals of the Academy of Medicine Singapore, vol. 33, no. 4, pp. 527–529, 2004. View at Google Scholar · View at Scopus
  36. S. M. Jain, S. Wesson, A. Hassanein et al., “Nephrogenic fibrosing dermopathy in pediatric patients,” Pediatric Nephrology, vol. 19, no. 4, pp. 467–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Gremmels and G. A. Kirk, “Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant: nephrogenic fibrosing dermopathy and graft vs host disease,” Clinical Nuclear Medicine, vol. 29, no. 11, pp. 694–697, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Chiu, G. Wells, H. Carag, E. Canova, and R. J. Firpi, “Nephrogenic fibrosing dermopathy: a rare entity in patients awaiting liver transplantation,” Liver Transplantation, vol. 10, no. 3, pp. 465–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. V. P. Sreenarasimhaiah, W. W. Brown, C. Cortese et al., “A report on four new cases of nephrogenic fibrosing dermopathy in chronic hemodialysis patients,” Hemodialysis International, vol. 8, no. 4, pp. 404–408, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Hershko, C. Hull, L. Ettefagh et al., “A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: a syndrome of dysregulated matrix remodeling?” Journal of Cutaneous Pathology, vol. 31, no. 3, pp. 262–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Obermoser, M. Emberger, M. Wieser, and B. Zelger, “Nephrogenic fibrosing dermopathy in two patients with systemic lupus erythematosus,” Lupus, vol. 13, no. 8, pp. 609–612, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Ortonne, D. Lipsker, F. Chantrel, N. Boehm, E. Grosshans, and B. Cribier, “Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nepharogenic fibrosing dermopathy: a new pathogenic hypothesis,” British Journal of Dermatology, vol. 150, no. 5, pp. 1050–1052, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Dundová, V. Treska, V. Simanek, and M. Michal, “Nephrogenic fibrosing dermopathy: a case study,” Transplantation Proceedings, vol. 37, no. 10, pp. 4187–4190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Dupont, V. Majithia, S. Ahmad, and R. McMurray, “Nephrogenic fibrosing dermopathy, a new mimicker of systemic sclerosis,” American Journal of the Medical Sciences, vol. 330, no. 4, pp. 192–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. A. S. Glaich, P. T. Martinelli, R. F. Markus, and S. Hsu, “Generalized elastolysis following nephrogenic fibrosing dermopathy,” Journal of the American Academy of Dermatology, vol. 53, no. 1, pp. 174–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. S. R. Daram, C. M. Cortese, and B. Bastani, “Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review,” American Journal of Kidney Diseases, vol. 46, no. 4, pp. 754–759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Schmook, K. Budde, C. Ulrich, H. H. Neumayer, L. Fritsche, and E. Stockfleth, “Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy,” Nephrology Dialysis Transplantation, vol. 20, no. 1, pp. 220–222, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Gilliet, A. Cozzio, G. Burg, and F. O. Nestle, “Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis,” British Journal of Dermatology, vol. 152, no. 3, pp. 531–536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. E. Gibson, C. F. Farver, and R. A. Prayson, “Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature,” Archives of Pathology and Laboratory Medicine, vol. 130, no. 2, pp. 209–212, 2006. View at Google Scholar · View at Scopus
  50. J. B. DiCarlo, E. A. Gupta, and A. R. Solomon, “A pediatric case of nephrogenic fibrosing dermopathy: improvement after combination therapy,” Journal of the American Academy of Dermatology, vol. 54, no. 5, pp. 914–916, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. T. B. Cassis, J. M. Jackson, G. B. Sonnier, and J. P. Callen, “Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis,” International Journal of Dermatology, vol. 45, no. 1, pp. 56–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Auron, L. Shao, and B. A. Warady, “Nephrogenic fibrosing dermopathy in children,” Pediatric Nephrology, vol. 21, no. 9, pp. 1307–1311, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Maloo, P. Abt, R. Kashyap et al., “Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update,” American Journal of Transplantation, vol. 6, no. 9, pp. 2212–2217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Thakral, J. Alhariri, and J. L. Abraham, “Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications,” Contrast Media and Molecular Imaging, vol. 2, no. 4, pp. 199–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Keyrouz and S. A. Rudnicki, “Neuromuscular involvement in nephrogenic systemic fibrosis,” Journal of Clinical Neuromuscular Disease, vol. 9, no. 2, pp. 297–302, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. P. P. M. Cheung and A. K. Dorai Raj, “Nephrogenic fibrosing dermopathy: a new clinical entity mimicking scleroderma,” Internal Medicine Journal, vol. 37, no. 2, pp. 139–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. A. S. Weiss, M. S. Lucia, and I. Teitelbaum, “A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis,” Nature Clinical Practice Nephrology, vol. 3, no. 2, pp. 111–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. L. Lim, H. Y. Lee, S. C. S. Low, L. P. Chan, N. S. G. Goh, and S. M. Pang, “Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature,” Clinical and Experimental Dermatology, vol. 32, no. 4, pp. 353–358, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. I. M. Wahba, E. L. Simpson, and K. White, “Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature,” American Journal of Transplantation, vol. 7, no. 10, pp. 2425–2432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. I. M. Wahba, K. White, M. Meyer, and E. L. Simpson, “The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy—report of two cases and review of the literature,” Nephrology Dialysis Transplantation, vol. 22, no. 2, pp. 631–636, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Sanchez-Ross, R. Snyder, M. I. Colome-Grimmer, M. Blumberg, Y. Huttenbach, and S. Raimer, “Nephrogenic fibrosing dermopathy in a patient with systemic lupus erythematosus and acute lupus nephritis,” Pediatric Dermatology, vol. 24, no. 5, pp. E36–E39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Pieringer, B. Schmekal, O. Janko, and G. Biesenbach, “Treatment with corticosteroids does not seem to benefit nephrogenic systemic fibrosis,” Nephrology Dialysis Transplantation, vol. 22, no. 10, p. 3094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. C. W. Tsai, C. C. Chao, V. C. Wu, C. H. Hsiao, and Y. M. Chen, “Nephrogenic fibrosing dermopathy in a peritoneal dialysis patient,” Kidney International, vol. 72, no. 10, p. 1294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. N. B. Aires, M. N. Sotto, and M. M. S. Nico, “Nephrogenic fibrosing dermopathy: report of two cases,” Acta Dermato-Venereologica, vol. 87, no. 6, pp. 521–524, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Hamilton-Persaud, L. D. Ezell, and J. G. Macklin, “Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis,” Nephrology Nursing Journal, vol. 34, no. 3, pp. 283–288, 2007. View at Google Scholar · View at Scopus
  66. J. A. Moreno-Romero, S. Segura, J. J. M. Mascaro Jr. et al., “Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor,” British Journal of Dermatology, vol. 157, no. 4, pp. 783–787, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Yerram, G. Saab, P. R. Karuparthi, M. R. Hayden, and R. Khanna, “Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure—role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 2, pp. 258–263, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. D. S. Goddard, C. C. Magee, A. J. F. Lazar, and D. M. Miller, “Nephrogenic fibrosing dermopathy with recurrence after allograft failure,” Journal of the American Academy of Dermatology, vol. 56, no. 5, supplement, pp. S109–S111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Khurana, V. M. Runge, M. Narayanan, J. F. Greene Jr., and A. E. Nickel, “Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (Omniscan),” Investigative Radiology, vol. 42, no. 2, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Clorius, K. Technau, T. Watter et al., “Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent,” Clinical Nephrology, vol. 68, no. 4, pp. 249–252, 2007. View at Google Scholar · View at Scopus
  71. H. Richmond, J. Zwerner, Y. Kim, and D. Fiorentino, “Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis,” Archives of Dermatology, vol. 143, no. 8, pp. 1025–1030, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. R. E. Kalb, T. N. Helm, H. Sperry, C. Thakral, J. L. Abraham, and E. Kanal, “Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury,” British Journal of Dermatology, vol. 158, no. 3, pp. 607–610, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. E. Saussereau, C. Lacroix, A. Cattaneo, L. Mahieu, and J. P. Goulle, “Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis,” Forensic Science International, vol. 176, no. 1, pp. 54–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Bainotti, E. Rota, M. Bertrero, O. Tamburrini, A. Balducci, and M. Formica, “Nephrogenic systemic fibrosis: the first Italian gadolinium-proven case,” Clinical Nephrology, vol. 70, no. 6, pp. 514–517, 2008. View at Google Scholar · View at Scopus
  75. J. Sharma, A. Mongia, M. Schoenaman, S. Chang, A. D'Angelo, and M. Rao, “Nephrogenic fibrosing dermatopathy, cardiac calcification and pulmonary hypertension in an adolescent on chronic hemodialysis,” Indian Journal of Nephrology, vol. 18, no. 2, pp. 70–73, 2008. View at Publisher · View at Google Scholar
  76. B. F. Firoz, C. M. Hunzeker, A. C. Soldano, and A. G. Franks Jr., “Nephrogenic fibrosing dermopathy,” Dermatology Online Journal, vol. 14, no. 5, article 11, 2008. View at Google Scholar · View at Scopus
  77. S. Digby, E. MacDuff, K. Blessing, and S. Holmes, “Nephrogenic systemic fibrosis: a histopathological study of eight cases of a recently described entity,” Histopathology, vol. 52, no. 4, pp. 531–534, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. C. C. Chao, C. C. Yang, C. H. Hsiao, M. K. Pan, C. H. Lin, and S. T. Hsieh, “Nephrogenic systemic fibrosis associated with gadolinium use,” Journal of the Formosan Medical Association, vol. 107, no. 3, pp. 270–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Sego, “Nephrogenic fibrosing dermopathy: a case study,” Nephrology Nursing Journal, vol. 35, no. 1, pp. 67–68, 2008. View at Google Scholar · View at Scopus
  80. P. Marckmann, A. H. Nielsen, and J. J. Sloth, “Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis,” Nephrology Dialysis Transplantation, vol. 23, no. 10, pp. 3280–3282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Shin, S. R. Granter, J. S. Coblyn, and S. Gupta, “Progressive arm and leg stiffness in a patient with chronic renal impairment,” Nature Clinical Practice Rheumatology, vol. 4, no. 10, pp. 557–562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Dhungel, R. Lattupalli, and J. Topf, “Nephrogenic fibrosing dermopathy,” The Scientific World Journal, vol. 8, pp. 164–165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Caccetta and J. J. Chan, “Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium,” Australasian Journal of Dermatology, vol. 49, no. 1, pp. 48–51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. N. S. Anavekar, A. H. Chong, R. Norris, J. Dowling, and D. Goodman, “Nephrogenic systemic fibrosis in a gadolinium-naive renal transplant recipient,” Australasian Journal of Dermatology, vol. 49, no. 1, pp. 44–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Nagai, M. Hasegawa, K. Shinmi et al., “Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia,” Acta Dermato-Venereologica, vol. 88, no. 6, pp. 597–600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Khurana, A. E. Nickel, J. F. Greene Jr., M. Narayanan, W. A. High, and C. J. Foulks, “Successful pregnancy in a hemodialysis patient and marked resolution of her nephrogenic systemic fibrosis,” American Journal of Kidney Diseases, vol. 51, no. 6, pp. e29–e32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Kreuter, T. Gambichler, S. M. Weiner, and G. Schieren, “Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis,” Archives of Dermatology, vol. 144, no. 11, pp. 1527–1529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Singh, A. Davenport, I. Clatworthy et al., “A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?” British Journal of Dermatology, vol. 158, no. 6, pp. 1358–1362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. P. Marckmann, “An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital,” European Journal of Radiology, vol. 66, no. 2, pp. 187–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. K. Nakai, K. Takeda, H. Kimura, S. Miura, and A. Maeda, “Nephrogenic systemic fibrosis in a patient on long-term hemodialysis,” Clinical Nephrology, vol. 71, no. 2, pp. 217–220, 2009. View at Google Scholar · View at Scopus
  91. J. Song, S. Volkov, C. R. Shea et al., “Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases,” Journal of Cutaneous Pathology, vol. 36, supplement 1, pp. 31–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. C. Foss, J. K. Smith, L. Ortiz, C. Hanevold, and L. Davis, “Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy,” Pediatric Dermatology, vol. 26, no. 5, pp. 579–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. K. H. N. Chan, W. Y. M. Tang, K. C. Hau et al., “Nephrogenic systemic fibrosis in a Chinese renal-transplant recipient,” Clinical and Experimental Dermatology, vol. 34, no. 2, pp. 244–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. C. F. Lu, C. H. Hsiao, and J. W. Tjiu, “Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 3, pp. 339–340, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. A. F. Koreishi, R. M. Nazarian, A. J. Saenz et al., “Nephrogenic systemic fibrosis: a pathologic study of autopsy cases,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 12, pp. 1943–1948, 2009. View at Google Scholar · View at Scopus
  96. A. Al Habeeb, S. Partington, D. Rosenthal, and S. Salama, “Skin thickening in a hemodialysis patient: a case of nephrogenic fibrosing dermopathy,” Journal of Cutaneous Medicine and Surgery, vol. 13, no. 2, pp. 110–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. W. C. Chen, S. L. Huang, C. S. Huang et al., “Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan,” European Journal of Dermatology, vol. 19, no. 1, pp. 44–49, 2009. View at Google Scholar · View at Scopus
  98. R. S. Gist, D. W. Miller, and T. Warren, “A difficult airway in a patient with nephrogenic sclerosing fibrosis,” Anesthesia and Analgesia, vol. 110, no. 2, pp. 555–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Wilford, J. D. Fine, A. S. Boyd, S. Sanyal, J. L. Abraham, and S. M. Kantrow, “Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation,” American Journal of Dermatopathology, vol. 32, no. 1, pp. 71–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Tsushima, E. Kanal, and H. S. Thomsen, “Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases,” British Journal of Radiology, vol. 83, no. 991, pp. 590–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. H. Hoppe, S. Spagnuolo, J. M. Froehlich et al., “Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents,” European Radiology, vol. 20, no. 3, pp. 595–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Edgar, R. Woltjer, R. Whitham, S. H. Gultekin, S. Watnick, and E. J. Cupler, “Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation,” Neuromuscular Disorders, vol. 20, no. 6, pp. 411–413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. A. A. Lemy, V. del Marmol, A. Kolivras et al., “Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience,” Journal of the American Academy of Dermatology, vol. 63, no. 3, pp. 389–399, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. I. S. Reddy, V. K. Somani, G. Swarnalata, and S. Maitra, “Nephrogenic systemic fibrosis following hair-dye ingestion induced acute renal failure,” Indian Journal of Dermatology, Venereology and Leprology, vol. 76, no. 4, pp. 400–403, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. M. C. Cuffy, M. Singh, R. Formica et al., “Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature,” Nephrology Dialysis Transplantation, vol. 26, no. 3, pp. 1099–1101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. N. Bangsgaard, J. M. Hansen, P. Marckmann, and L. Skov, “Nephrogenic systemic fibrosis symptoms alleviated by renal transplantation,” Dialysis and Transplantation, vol. 40, no. 2, pp. 86–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. G. J. Fisher, S. Datta, Z. Wang et al., “c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid,” Journal of Clinical Investigation, vol. 106, no. 5, pp. 663–670, 2000. View at Google Scholar · View at Scopus
  108. S. Swaminathan, T. D. Horn, D. Pellowski et al., “Nephrogenic systemic fibrosis, gadolinium, and iron mobilization,” The New England Journal of Medicine, vol. 357, no. 7, pp. 720–722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. M. F. Bellin, “MR contrast agents, the old and the new,” European Journal of Radiology, vol. 60, no. 3, pp. 314–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Wang, M. C. Wilkes, E. B. Leof, and R. Hirschberg, “Imatinib mesylate blocks a non-Smad TGF-β pathway and reduces renal fibrogenesis in vivo,” The FASEB Journal, vol. 19, no. 1, pp. 1–11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. J. H. W. Distler, A. Jüngel, L. C. Huber et al., “Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis,” Arthritis and Rheumatism, vol. 56, no. 1, pp. 311–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Chandran, J. Petersen, C. Jacobs, D. Fiorentino, K. Doeden, and R. A. Lafayette, “Imatinib in the treatment of nephrogenic systemic fibrosis,” American Journal of Kidney Diseases, vol. 53, no. 1, pp. 129–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. J. M. Idée, M. Port, I. Raynal, M. Schaefer, S. Le Greneur, and C. Corot, “Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review,” Fundamental and Clinical Pharmacology, vol. 20, no. 6, pp. 563–576, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Okada, K. Katagiri, T. Kumazaki, and H. Yokoyama, “Safety of gadolinium contrast agent in hemodialysis patients,” Acta Radiologica, vol. 42, no. 3, pp. 339–341, 2001. View at Google Scholar · View at Scopus
  115. J. Haustein and G. Schumann-Giampieri, “Elimination of Gd-DTPA by means of hemodialysis,” European Journal of Radiology, vol. 11, no. 3, pp. 227–229, 1990. View at Publisher · View at Google Scholar · View at Scopus
  116. T. Saitoh, K. Hayasaka, Y. Tanaka, T. Kuno, and Y. Nagura, “Dialyzability of gadodiamide in hemodialysis patients,” Radiation Medicine, vol. 24, no. 6, pp. 445–451, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. N. Leung, M. R. Pittelkow, C. U. Lee, J. A. Good, M. M. Hanley, and T. P. Moyer, “Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis,” NDT Plus, vol. 2, no. 4, pp. 309–311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. J. L. Abraham, C. Thakral, L. Skov, K. Rossen, and P. Marckmann, “Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis,” British Journal of Dermatology, vol. 158, no. 2, pp. 273–280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. S. E. Cowper, “Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy,” American Journal of Kidney Diseases, vol. 46, no. 4, pp. 763–765, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. P. Stenvinkel, “Inflammatory and atherosclerotic interactions in the depleted uremic patient,” Blood Purification, vol. 19, no. 1, pp. 53–61, 2001. View at Google Scholar · View at Scopus
  121. J. J. Carrero and P. Stenvinkel, “Inflammation in end-stage renal disease—what have we learned in 10 years?” Seminars in Dialysis, vol. 23, no. 5, pp. 498–509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. G. A. Kaysen, J. A. Dubin, H. G. Müller, L. M. Rosales, and N. W. Levin, “The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group,” Kidney International, vol. 58, no. 1, pp. 346–352, 2000. View at Publisher · View at Google Scholar · View at Scopus
  123. L. Gesualdo, G. Pertosa, G. Grandaliano, and F. P. Schena, “Cytokines and bioincompatibility,” Nephrology Dialysis Transplantation, vol. 13, no. 7, pp. 1622–1626, 1998. View at Publisher · View at Google Scholar · View at Scopus
  124. V. Panichi, G. M. Rizza, D. Taccola et al., “C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes,” Biomedicine & Pharmacotherapy, vol. 60, no. 1, pp. 14–17, 2006. View at Publisher · View at Google Scholar
  125. S. L. Goldstein, H. Currier, L. Watters, J. M. Hempe, R. D. Sheth, and D. Silverstein, “Acute and chronic inflammation in pediatric patients receiving hemodialysis,” Journal of Pediatrics, vol. 143, no. 5, pp. 653–657, 2003. View at Publisher · View at Google Scholar · View at Scopus